Biotech Values

[apljack]

NEO: Beats on revenue and earnings (Modestly)

NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013

http://finance.yahoo.com/news/neogenomics-reports-record-revenue-18-120000653.html

(Sorry for the lack of response to your last post Dew, I have been covered up with work and college campus visits. NEO has a high beta and the drop appeared to be part of the near market correction. Todays earnings report is, IMO, good but not great. I'll wait for the CC to hear how the CVD partnership is working out. Just an aside, ABT reduced their position in the co. from 4.9 million to 800K shares during the quarter.)

Question for DT: Last time we discussed this co. regarding their publication of a journal article regarding the MelanoSite Melanoma test, we determined that the journal was low tier and the publication was essentially meaningless. The co. announced that they have published an article regarding their genetic prostate Ca test in the journal Genetic Testing and Molecular Biomarkers , any opinions regarding the quality of this journal?